These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 7758397

  • 1. Biliary elimination and hepatic disposition of an association of piperacillin and tazobactam: experimental evaluation.
    Brogard JM, Caro-Sampara F, Westphal JF, Blickle JF, Jehl F.
    Drugs Exp Clin Res; 1994; 20(6):247-55. PubMed ID: 7758397
    [Abstract] [Full Text] [Related]

  • 2. Biliary pharmacokinetic profile of piperacillin: experimental data and evaluation in man.
    Brogard JM, Jehl F, Blickle JF, Dorner M, Arnaud JP, Monteil H.
    Int J Clin Pharmacol Ther Toxicol; 1990 Nov; 28(11):462-70. PubMed ID: 2272706
    [Abstract] [Full Text] [Related]

  • 3. [Biliary elimination and hepatic disposition of piperacillin: experimental evaluation].
    Brogard JM, Dorner M, Blickle JF, Jehl F, Monteil H.
    Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):495-9. PubMed ID: 2385445
    [Abstract] [Full Text] [Related]

  • 4. Biliary elimination and hepatic disposition of a new fluoroquinolone, temafloxacin: experimental evaluation.
    Brogard JM, Koechlin C, Westphal JF, Blicklé JF, Dorner M, Jehl F.
    Drugs Exp Clin Res; 1990 Jun; 16(8):407-16. PubMed ID: 2097145
    [Abstract] [Full Text] [Related]

  • 5. [Biliary diffusion of tazocillin in man].
    Brogard JM, Caro-Sampara F, Westphal JF, Jehl F.
    Pathol Biol (Paris); 1999 Oct; 47(8):836-44. PubMed ID: 10573704
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of cefixime biliary disposition in the isolated perfused rabbit liver model and in humans.
    Westphal JF, Brogard JM, Jehl F, Schloegel M, Blickle JF, Monteil H.
    Drugs Exp Clin Res; 1992 Oct; 18(8):329-36. PubMed ID: 1292915
    [Abstract] [Full Text] [Related]

  • 7. Assessment of biliary excretion of piperacillin-tazobactam in humans.
    Westphal JF, Brogard JM, Caro-Sampara F, Adloff M, Blicklé JF, Monteil H, Jehl F.
    Antimicrob Agents Chemother; 1997 Aug; 41(8):1636-40. PubMed ID: 9257733
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics and tissue penetration of piperacillin/tazobactam with particular reference to its potential in abdominal and soft tissue infections.
    Sörgel F, Kinzig M.
    Eur J Surg Suppl; 1994 Aug; (573):39-44. PubMed ID: 7524794
    [Abstract] [Full Text] [Related]

  • 9. Biliary elimination of ticarcillin plus clavulanic acid (Claventin): experimental and clinical study.
    Brogard JM, Jehl F, Blickle JF, Adloff M, Dorner M, Montell H.
    Int J Clin Pharmacol Ther Toxicol; 1989 Mar; 27(3):135-44. PubMed ID: 2722309
    [Abstract] [Full Text] [Related]

  • 10. [Experimental study on the hepatobiliary kinetics and excretion of temafloxacin. Evidence for production of active metabolites by the rabbit liver].
    Brogard JM, Westphal JF, Koechlin C, Jehl F, Dorner M, Blickle JF, Monteil H.
    Pathol Biol (Paris); 1991 May; 39(5):524-9. PubMed ID: 1881688
    [Abstract] [Full Text] [Related]

  • 11. [Biliary excretion of apalcillin. Experimental study and evaluation in man].
    Brogard JM, Adloff M, Pinget M, Dorner M, Lautier F.
    Pathol Biol (Paris); 1985 Feb; 33(2):121-8. PubMed ID: 3889782
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics of piperacillin, tazobactam and its metabolite in renal impairment.
    Derendorf H, Dalla Costa T.
    Int J Clin Pharmacol Ther; 1996 Nov; 34(11):482-8. PubMed ID: 8937930
    [Abstract] [Full Text] [Related]

  • 13. [Cefpiramide, a new cephalosporin with high hepatic elimination; experimental evaluation of its biliary passage and disposition in the liver].
    Brogard JM, Blickle JF, Adloff M, Jehl F, Monteil H.
    Pathol Biol (Paris); 1989 May; 37(5):418-23. PubMed ID: 2780097
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetic-pharmacodynamic modelling of the in vitro antiinfective effect of piperacillin-tazobactam combinations.
    Dalla Costa T, Nolting A, Rand K, Derendorf H.
    Int J Clin Pharmacol Ther; 1997 Oct; 35(10):426-33. PubMed ID: 9352391
    [Abstract] [Full Text] [Related]

  • 15. [Experimental evaluation of the biliary tract passage of ceftriaxone and its hepatic disposition].
    Brogard JM, Blickle JF, Jehl F, Dorner M, Monteil H.
    Pathol Biol (Paris); 1987 May; 35(5):441-7. PubMed ID: 3302844
    [Abstract] [Full Text] [Related]

  • 16. Stability of piperacillin sodium-tazobactam sodium and ranitidine hydrochloride in 0.9% sodium chloride injection during simulated Y-site administration.
    Choi JS, Burm JP, Jhee SS, Chin A, Ulrich RW, Gill MA.
    Am J Hosp Pharm; 1994 Sep 15; 51(18):2273-6. PubMed ID: 7801988
    [Abstract] [Full Text] [Related]

  • 17. Experimental and clinical evaluation of the biliary pharmacokinetic profile of cefpiramide, a new cephalosporin with high hepatic elimination.
    Brogard JM, Jehl F, Blickle JF, Arnaud JP, Monteil H.
    Drugs Exp Clin Res; 1988 Sep 15; 14(8):519-27. PubMed ID: 3248507
    [Abstract] [Full Text] [Related]

  • 18. Alveolar concentrations of piperacillin/tazobactam administered in continuous infusion to patients with ventilator-associated pneumonia.
    Boselli E, Breilh D, Rimmelé T, Guillaume C, Xuereb F, Saux MC, Bouvet L, Chassard D, Allaouchiche B.
    Crit Care Med; 2008 May 15; 36(5):1500-6. PubMed ID: 18434883
    [Abstract] [Full Text] [Related]

  • 19. Serum piperacillin/tazobactam pharmacokinetics in a morbidly obese individual.
    Newman D, Scheetz MH, Adeyemi OA, Montevecchi M, Nicolau DP, Noskin GA, Postelnick MJ.
    Ann Pharmacother; 2007 Oct 15; 41(10):1734-9. PubMed ID: 17726066
    [Abstract] [Full Text] [Related]

  • 20. Impact of tazobactam pharmacokinetics on the antimicrobial effect of piperacillin-tazobactam combinations.
    Liu Q, Rand K, Derendorf H.
    Int J Antimicrob Agents; 2004 May 15; 23(5):494-7. PubMed ID: 15120729
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.